142 related articles for article (PubMed ID: 23037725)
1. [Treatment strategy for adult acute lymphoblastic leukemia].
Takeuchi J
Rinsho Ketsueki; 2012 Oct; 53(10):1528-37. PubMed ID: 23037725
[No Abstract] [Full Text] [Related]
2. [Treatment strategy for childhood acute lymphoblastic leukemia].
Horibe K
Rinsho Ketsueki; 2012 Oct; 53(10):1538-48. PubMed ID: 23037726
[No Abstract] [Full Text] [Related]
3. Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group.
Krejci O; van der Velden VH; Bader P; Kreyenberg H; Goulden N; Hancock J; Schilham MW; Lankester A; Révész T; Klingebiel T; van Dongen JJ
Bone Marrow Transplant; 2003 Oct; 32(8):849-51. PubMed ID: 14520434
[No Abstract] [Full Text] [Related]
4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
Biol Blood Marrow Transplant; 2006 Jan; 12(1):1-30. PubMed ID: 16399566
[TBL] [Abstract][Full Text] [Related]
5. Eliminating a gold standard in childhood acute lymphoblastic leukemia?
Raetz EA; Carroll WL
Pediatr Blood Cancer; 2006 Sep; 47(3):242-4. PubMed ID: 16421903
[No Abstract] [Full Text] [Related]
6. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.
Oliansky DM; Camitta B; Gaynon P; Nieder ML; Parsons SK; Pulsipher MA; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2012 Jul; 18(7):979-81. PubMed ID: 22490784
[No Abstract] [Full Text] [Related]
7. The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
Ma X; Wu D; Sun A; Qiu H; Fu Z; Wu X; Chen S; Mohty M
Am J Hematol; 2010 Feb; 85(2):141-2. PubMed ID: 20029991
[No Abstract] [Full Text] [Related]
8. Current therapeutic strategies in adult acute lymphoblastic leukemia.
Fielding AK
Hematol Oncol Clin North Am; 2011 Dec; 25(6):1255-79, viii. PubMed ID: 22093586
[TBL] [Abstract][Full Text] [Related]
9. [Acute lymphoblastic leukemia in the adult].
Gökbuget N
Dtsch Med Wochenschr; 2011 Dec; 136(48):2466-9. PubMed ID: 22109577
[No Abstract] [Full Text] [Related]
10. [Guideline, acute lymphoblastic leukemia].
Akiyama H
Rinsho Ketsueki; 2013 Oct; 54(10):1737-45. PubMed ID: 24064824
[No Abstract] [Full Text] [Related]
11. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Shin HJ; Chung JS; Cho GJ
Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
[No Abstract] [Full Text] [Related]
12. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study.
Martino R; Giralt S; Caballero MD; Mackinnon S; Corradini P; Fernández-Avilés F; San Miguel J; Sierra J
Haematologica; 2003 May; 88(5):555-60. PubMed ID: 12745275
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies.
Aljurf M; Zaidi SZ
Biol Blood Marrow Transplant; 2005 Oct; 11(10):739-54. PubMed ID: 16182175
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
Shaw BE; Russell NH
Bone Marrow Transplant; 2008 Mar; 41(5):495-503. PubMed ID: 17952130
[TBL] [Abstract][Full Text] [Related]
15. Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia.
Gökbuget N; Hoelzer D
Haematologica; 2003 May; 88(5):484-6. PubMed ID: 12745266
[No Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis.
Bartolozzi B; Bosi A; Orsi C
Cancer; 2007 Jan; 109(2):343; author reply 344. PubMed ID: 17154182
[No Abstract] [Full Text] [Related]
17. Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
Herold R; von Stackelberg A; Hartmann R; Eisenreich B; Henze G
J Clin Oncol; 2004 Feb; 22(3):569-70; author reply 570-1. PubMed ID: 14752084
[No Abstract] [Full Text] [Related]
18. Modern therapy of acute lymphoblastic leukemia.
Bassan R; Hoelzer D
J Clin Oncol; 2011 Feb; 29(5):532-43. PubMed ID: 21220592
[TBL] [Abstract][Full Text] [Related]
19. [Hematopoietic stem cell transplantation should be performed in all patients with adult acute lymphoblastic leukemia in first complete remission].
Ota S
Rinsho Ketsueki; 2012 Jun; 53(6):594-603. PubMed ID: 22790634
[No Abstract] [Full Text] [Related]
20. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia.
Rubnitz JE
J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
